InvestorsHub Logo
Followers 369
Posts 10529
Boards Moderated 0
Alias Born 12/03/2009

Re: None

Tuesday, 05/22/2018 9:31:58 AM

Tuesday, May 22, 2018 9:31:58 AM

Post# of 330573
Sales are down AGAIN from first Q 2017...

Some try using NHS, and now starting April 1st. When all along its said sales will increase after FDA. They have steadily gone down since FDA clearance.

England isnt going to save this mess. 72% of the globe(without the USA), then include America now, can buy and the sales keep dropping. Further proof, no repeat sales, or sales would at least be climbing. They are not.

Sales down and hundreds of millions of new shares added. Proof they arent profitable. They still lose money hand over fist.

19.3 Billion float and $388k in sales and this is way way way too high a pps. Not justified at all.

First Quarter
2017 $401k
2018 $388k.

What a mess this company is. And closing in on 20 Billion float = SCARY
https://backend.otcmarkets.com/otcapi/company/financial-report/193420/content

Common stock, par value $0.001 per share, 20,000,000,000 19,336,137 18,991,663
shares authorized at March 31, 2018 and December 31,
2017, and 19,336,137.045 and 18,991,662,712 shares
issued and outstanding at March 31, 2018 and
December 31, 2017, respectively